RET and hyperparathyroidism: As MEN2A patients develop hyperparathyroidism and/or pheochromocytoma that is not typically detected in FMTC, these findings suggest that the RET-C634 mutation is correlated with increased predisposition to develop MEN2A due to enhanced RET activity.